[Advances on Thrombopoietin Receptor Agonist in Severe Aplastic Anemia]

Overview

Journal Zhonghua Xue Ye Xue Za Zhi

Specialty Hematology

Date 2017 Oct 31

PMID 29081205

Citations 1

Authors

J Du

F K Zhang

Affiliations

Soon will be listed here.

Citing Articles

Knowledge map of thrombopoietin receptor agonists: A bibliometric analysis.

Hu R, Guo S, Liu M Heliyon. 2024; 10(1):e24051.

PMID: 38268581 PMC: 10806291. DOI: 10.1016/j.heliyon.2024.e24051.

References

Dasouki M, Rafi S, Olm-Shipman A, Wilson N, Abhyankar S, Ganter B . Exome sequencing reveals a thrombopoietin ligand mutation in a Micronesian family with autosomal recessive aplastic anemia. Blood. 2013; 122(20):3440-9. PMC: 3829117. DOI: 10.1182/blood-2012-12-473538. View

Kimura S, Roberts A, Metcalf D, Alexander W . Hematopoietic stem cell deficiencies in mice lacking c-Mpl, the receptor for thrombopoietin. Proc Natl Acad Sci U S A. 1998; 95(3):1195-200. PMC: 18717. DOI: 10.1073/pnas.95.3.1195. View

Townsley D, Desmond R, Dunbar C, Young N . Pathophysiology and management of thrombocytopenia in bone marrow failure: possible clinical applications of TPO receptor agonists in aplastic anemia and myelodysplastic syndromes. Int J Hematol. 2013; 98(1):48-55. PMC: 4144663. DOI: 10.1007/s12185-013-1352-6. View

Sanjuan-Pla A, Macaulay I, Jensen C, Woll P, Luis T, Mead A . Platelet-biased stem cells reside at the apex of the haematopoietic stem-cell hierarchy. Nature. 2013; 502(7470):232-6. DOI: 10.1038/nature12495. View

Gill H, Leung G, Lopes D, Kwong Y . The thrombopoietin mimetics eltrombopag and romiplostim in the treatment of refractory aplastic anaemia. Br J Haematol. 2016; 176(6):991-994. DOI: 10.1111/bjh.14024. View

Sitnicka E, Lin N, Priestley G, Fox N, Broudy V, WOLF N . The effect of thrombopoietin on the proliferation and differentiation of murine hematopoietic stem cells. Blood. 1996; 87(12):4998-5005. View

Kaushansky K . Molecular mechanisms of thrombopoietin signaling. J Thromb Haemost. 2009; 7 Suppl 1:235-8. DOI: 10.1111/j.1538-7836.2009.03419.x. View

Solberg Jr L . Biologic aspects of thrombopoietins and the development of therapeutic agents. Curr Hematol Rep. 2005; 4(6):423-8. View

Alexander W, Roberts A, Nicola N, Li R, Metcalf D . Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietic receptor c-Mpl. Blood. 1996; 87(6):2162-70. View

10.

Fox N, Priestley G, Papayannopoulou T, Kaushansky K . Thrombopoietin expands hematopoietic stem cells after transplantation. J Clin Invest. 2002; 110(3):389-94. PMC: 151089. DOI: 10.1172/JCI15430. View

11.

Wang H, Dong Q, Fu R, Qu W, Ruan E, Wang G . Recombinant human thrombopoietin treatment promotes hematopoiesis recovery in patients with severe aplastic anemia receiving immunosuppressive therapy. Biomed Res Int. 2015; 2015:597293. PMC: 4377357. DOI: 10.1155/2015/597293. View

12.

Wagemaker G, Neelis K, Hartong S, Wognum A, Thomas G, Fielder P . The efficacy of recombinant thrombopoietin in murine and nonhuman primate models for radiation-induced myelosuppression and stem cell transplantation. Stem Cells. 1998; 16(6):375-86. DOI: 10.1002/stem.160375. View

13.

Kaushansky K, Lin N, Grossmann A, Humes J, Sprugel K, Broudy V . Thrombopoietin expands erythroid, granulocyte-macrophage, and megakaryocytic progenitor cells in normal and myelosuppressed mice. Exp Hematol. 1996; 24(2):265-9. View

14.

Scheinberg P, Young N . How I treat acquired aplastic anemia. Blood. 2012; 120(6):1185-96. PMC: 3418715. DOI: 10.1182/blood-2011-12-274019. View

15.

Kaushansky K, Lok S, Holly R, Broudy V, Lin N, BAILEY M . Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature. 1994; 369(6481):568-71. DOI: 10.1038/369568a0. View

16.

Wang C, Zhang B, Wang S, Zhang J, Liu Y, Wang J . Recombinant human thrombopoietin promotes hematopoietic reconstruction after severe whole body irradiation. Sci Rep. 2015; 5:12993. PMC: 4585893. DOI: 10.1038/srep12993. View

17.

Li J, Yang C, Xia Y, Bertino A, Glaspy J, Roberts M . Thrombocytopenia caused by the development of antibodies to thrombopoietin. Blood. 2001; 98(12):3241-8. DOI: 10.1182/blood.v98.12.3241. View

18.

Chen Q, Solar G, Eaton D, de Sauvage F . IL-3 does not contribute to platelet production in c-Mpl-deficient mice. Stem Cells. 2000; 16 Suppl 2:31-6. DOI: 10.1002/stem.5530160706. View

19.

de Sauvage F, Luoh S, Ryan A, Dowd M, Eaton D, Moore M . Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin. J Exp Med. 1996; 183(2):651-6. PMC: 2192470. DOI: 10.1084/jem.183.2.651. View

20.

Isik A, Eliacik E, Haznedaroglu I, Aksu S, Sayinalp N, Buyukasik Y . The impact of eltrombopag administration on the clinical course of severe refractory fatal acquired aplastic anemia. Turk J Haematol. 2014; 30(3):328-30. PMC: 3878545. DOI: 10.4274/Tjh-2013.0005. View